Table 1.
Study | Age/Sex | Pulmonary tuberculosis | Treated levels | Infected levels | Time to infection | Mode of therapy | Outcome |
---|---|---|---|---|---|---|---|
Bouvresseet al.8 | 69/M | No | T12–L5 PVP | L5 | 1 month | Surgery, antituberculous medications | Cured |
Ivo et al.9 | 70/M | Yes | L1 PKP | L1 | 2 weeks | Surgery, antituberculous medications | Died because of multiorgan failure |
Kim et al.10 | 76/F | No | T12, L1 PKP | T12, L1 | 3 years | Surgery, antituberculous medications | Cured |
Kang et al.11 | 58/F | Yes | T12 PVP | T11, 12 | 3 weeks | Surgery, antituberculous medications | Cured |
Zou et al.12 | 68/F | Yes | L2 PVP | L1, L2, L3 | 3 months | Antituberculous medications | Cured |
67/F | Yes | L3 PKP | L2, L3 | 1 month | Surgery, antituberculous medications | Cured | |
Ge et al.13 | 61/F | No | L1 PKP | T9–L1 | 12 months | Surgery, antituberculous medications | Cured |
Current study | 54/F | Yes | L3 PKP | L2, L3 | 7 months | Surgery, antituberculous medications | Cured |
M, male; F, female; PVP, percutaneous vertebroplasty; PKP, percutaneous kyphoplasty.